Skip to main content
. 2016 Nov 24;9:6987–6998. doi: 10.2147/OTT.S110985

Figure 6.

Figure 6

Kaplan–Meier survival analysis of coexpression of USP22, BMI1, and EZH2 in the testing set and overall patients.

Notes: Higher expression of USP22, BMI1, and EZH2 was closely correlated with poor recurrence-free survival (A) and overall survival (B) in the testing set. Overall, patients with higher USP22, BMI1, and EZH2 expression also showed inferior recurrence-free survival (C) and overall survival (D).